Mapping disease-related mutations of SRD5A2 to our structure also provides feasible molecular mechanisms for the effects of those mutations in 5α-reductase deficiency. This evidence concerns the gene SRD5A2 and hyperinsulinemic hypoglycemia, familial, 4.